🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/06/2018 | 59,90 | 59,98 | 59,24 | 59,48 | -0,40% | 1,24% | 7.542.666 |
| 08/06/2018 | 59,17 | 59,78 | 59,13 | 59,71 | +0,95% | 1,10% | 10.142.754 |
| 07/06/2018 | 59,16 | 59,20 | 58,69 | 59,15 | +0,10% | 0,85% | 7.910.933 |
| 06/06/2018 | 58,69 | 59,10 | 58,42 | 59,09 | +0,88% | 1,17% | 7.912.190 |
| 05/06/2018 | 59,16 | 59,48 | 58,26 | 58,58 | -1,02% | 2,05% | 13.098.218 |
| 04/06/2018 | 58,73 | 59,67 | 58,38 | 59,18 | +2,41% | 2,19% | 20.410.534 |
| 01/06/2018 | 57,15 | 58,02 | 56,89 | 57,79 | +1,73% | 1,99% | 11.556.925 |
| 31/05/2018 | 56,90 | 57,14 | 56,59 | 56,80 | -0,32% | 0,96% | 12.786.019 |
| 30/05/2018 | 55,96 | 57,06 | 55,84 | 56,98 | +2,26% | 2,18% | 11.572.016 |
| 29/05/2018 | 55,90 | 56,19 | 55,37 | 55,73 | -1,17% | 1,47% | 9.228.269 |
| 25/05/2018 | 56,43 | 56,74 | 56,15 | 56,38 | -0,07% | 1,05% | 6.985.339 |
| 24/05/2018 | 56,54 | 56,69 | 56,12 | 56,42 | -0,07% | 1,01% | 7.261.382 |
| 23/05/2018 | 55,77 | 56,77 | 55,75 | 56,46 | +1,23% | 1,81% | 10.375.619 |
| 22/05/2018 | 56,09 | 56,43 | 55,73 | 55,77 | -0,20% | 1,26% | 9.357.068 |
| 21/05/2018 | 56,47 | 56,60 | 55,72 | 55,89 | -0,96% | 1,57% | 8.882.219 |
| 18/05/2018 | 56,26 | 56,74 | 54,86 | 56,43 | +0,12% | 3,34% | 10.151.242 |
| 17/05/2018 | 56,81 | 57,04 | 56,18 | 56,36 | -1,14% | 1,51% | 8.222.398 |
| 16/05/2018 | 56,60 | 57,26 | 56,40 | 57,01 | +0,93% | 1,52% | 8.941.222 |
| 15/05/2018 | 56,72 | 57,06 | 56,20 | 56,49 | -0,80% | 1,51% | 7.148.932 |
| 14/05/2018 | 57,03 | 57,33 | 56,71 | 56,95 | -0,02% | 1,09% | 9.942.062 |
| 11/05/2018 | 55,50 | 57,22 | 55,47 | 56,96 | +2,81% | 3,16% | 13.344.498 |
| 10/05/2018 | 55,47 | 56,04 | 55,28 | 55,40 | +0,19% | 1,38% | 8.624.097 |
| 09/05/2018 | 54,36 | 55,73 | 54,23 | 55,30 | +2,10% | 2,77% | 8.684.042 |
| 08/05/2018 | 54,74 | 54,79 | 53,68 | 54,16 | -1,08% | 2,02% | 10.749.546 |
| 07/05/2018 | 55,12 | 55,44 | 54,47 | 54,75 | -0,64% | 1,77% | 10.513.955 |
| 04/05/2018 | 54,50 | 55,26 | 54,23 | 55,11 | +0,38% | 1,89% | 9.149.983 |
| 03/05/2018 | 54,52 | 55,15 | 53,79 | 54,90 | +0,40% | 2,50% | 11.864.932 |
| 02/05/2018 | 55,04 | 55,34 | 54,41 | 54,68 | -1,17% | 1,70% | 10.921.837 |
| 01/05/2018 | 56,30 | 56,53 | 54,27 | 55,32 | -1,51% | 4,00% | 13.756.782 |
| 30/04/2018 | 56,92 | 57,23 | 56,17 | 56,17 | -1,01% | 1,86% | 13.730.267 |